SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-05-000421
Filing Date
2005-12-09
Accepted
2005-12-09 17:29:57
Documents
6
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a15271e10vq.htm 10-Q 624363
2 EXHIBIT 10.286 a15271exv10w286.txt EX-10.286 31471
3 EXHIBIT 31.1 a15271exv31w1.htm EX-31.1 6930
4 EXHIBIT 31.2 a15271exv31w2.htm EX-31.2 6917
5 EXHIBIT 32.1 a15271exv32w1.htm EX-32.1 3600
6 EXHIBIT 32.2 a15271exv32w2.htm EX-32.2 3593
  Complete submission text file 0000936392-05-000421.txt   678286
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 051256592
SIC: 2834 Pharmaceutical Preparations